PlainRecalls
FDA Drug Moderate Class II Terminated

Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) chewable,1 mg/0.02 mg/75 mg, Rx Only, Provides 24 days of active therapy, Pouch Contains one wallet of 28 tablets, NDC: 68180-911-11, Carton contains 3 wallets of 28 tablets each, NDC: 68180-911-13, Distributed by: Lupin Pharmaceuticals, Inc., MD, 21200, Manufactured by: Lupin Limited, India.

Reported: August 19, 2020 Initiated: July 21, 2020 #D-1502-2020

Product Description

Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) chewable,1 mg/0.02 mg/75 mg, Rx Only, Provides 24 days of active therapy, Pouch Contains one wallet of 28 tablets, NDC: 68180-911-11, Carton contains 3 wallets of 28 tablets each, NDC: 68180-911-13, Distributed by: Lupin Pharmaceuticals, Inc., MD, 21200, Manufactured by: Lupin Limited, India.

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification result observed in related substance test.

Details

Units Affected
560,922 Pouches
Distribution
Nationwide within the U.S.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) chewable,1 mg/0.02 mg/75 mg, Rx Only, Provides 24 days of active therapy, Pouch Contains one wallet of 28 tablets, NDC: 68180-911-11, Carton contains 3 wallets of 28 tablets each, NDC: 68180-911-13, Distributed by: Lupin Pharmaceuticals, Inc., MD, 21200, Manufactured by: Lupin Limited, India.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 560,922 Pouches.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification result observed in related substance test.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 19, 2020. Severity: Moderate. Recall number: D-1502-2020.